DYN EPS Estimates
Dyne Therapeutics, Inc.
$16.07
-$0.20(-1.23%)
37
Overall
50
Value
27
Tech
34
Quality
Market Cap
$3.04B
Volume
1.79M
52W Range
$14.00 - $27.31
Target Price
$36.00
DYN EPS estimates: the consensus estimate for Dyne Therapeutics, Inc.'s current fiscal year is -$3.59 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
DYN EPS Estimates
- EPS estimate, current quarter
- $-0.88
- EPS estimate, next quarter
- $-0.85
- EPS estimate, current year
- $-3.59
- EPS estimate, next year
- $-3.27
- EPS growth, 3-year
- -2.42%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.47 |
| 2024 | $-3.37 |
| 2023 | $-3.95 |
| 2022 | $-3.23 |
| 2021 | $-2.93 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DYN | $16.07 | -1.2% | 1.79M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |